ArticleJournal of experimental & clinical cancer research : CR2011

Clusterin is a potential molecular predictor for ovarian cancer patient's survival: targeting clusterin improves response to paclitaxel.

Mohamed K Hassan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.